Status:
COMPLETED
Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients
Lead Sponsor:
Cairo University
Conditions:
Office Hysteroscopy
Eligibility:
FEMALE
40-75 years
Phase:
PHASE4
Brief Summary
To compare the effectiveness of vaginal dinoprostone and vaginal misoprostol with placebo in minimizing the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to asse...
Detailed Description
hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of a...
Eligibility Criteria
Inclusion
- Menopausal patients with an indication for office hysteroscopy (postmenopausal bleeding or abnormal ultrasound findings)
Exclusion
- Nulliparous patients
- patients with cervical pathology
- retroverted uterus (detected by transvaginal ultrasound)
- previous cervical surgery
- patients with severe vaginal bleeding
- allergy or contraindications to dinoprostone or misoprostol therapy (asthma, liver, kidney, or heart disease).
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04044079
Start Date
August 20 2019
End Date
February 10 2020
Last Update
September 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Samy
Giza, Egypt, 11231